Cutaneous extramedullary hematopoiesis in a patient with secondary myelofibrosis due to MPL gene mutation
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.16990
Abstract: Dermal extramedullary hematopoiesis (EMH) is seen as a normal process from the first to the fifth month of gestation, and it is a process in which undifferentiated dermal mesenchymal cells retain their hematopoietic potential.1 However,… read more here.
Keywords: hematopoiesis; patient secondary; secondary myelofibrosis; hematopoiesis patient ... See more keywords